Abstract

Cardiac tamponade is a known life-threatening complication of extracorporeal membrane oxygenation (ECMO), often secondary to hemopericardium from major vascular or cardiac perforation. We present the unique case of a neonate with a milky pericardial effusion causing tamponade after ECMO cannulation, managed successfully with pericardial window. Understanding ECMO physiology and its effect on the classic presentation of tamponade is critical and can prevent delays in diagnosis. While hemopericardium is most commonly seen in these cases, findings of a non-bloody, milky effusion should prompt further workup for infection, chylopericardium or total parenteral nutrition-associated pericardial effusion, as the appropriate management can mitigate immediate and potential long-term sequelae.

INTRODUCTION

Extracorporeal membrane oxygenation (ECMO) remains a well-established supportive therapy for neonates with severe cardiac and respiratory failure refractory to maximal conventional management. Though lifesaving in many cases, serious potential complications remain. One rare complication, associated with significant morbidity, is inadvertent vascular or cardiac perforation during cannulation. This can result in hemopericardium and subsequent cardiac tamponade, requiring emergent intervention [1]. We present the unique case of a neonate developing cardiac tamponade within 24 h of ECMO cannulation, secondary to an unexpected milky pericardial effusion.

CASE REPORT

This case describes a female born via cesarean section at 41 weeks gestation to a healthy 33-year-old female, Gravida 1, Para 1. Upon delivery, thick meconium was seen in utero with worsening respiratory distress of the newborn, concerning for meconium aspiration. The patient eventually required intubation and echocardiogram was performed, showing a large patent ductus arteriosus, right ventricular dysfunction and severe pulmonary hypertension, with no pericardial effusion noted. She was placed on inhaled nitric oxide and total parenteral nutrition (TPN) was initiated via umbilical central venous catheter (CVC). Because of worsening oxygenation despite optimal ventilator settings, she was transferred to our Level-3 neonatal intensive care unit for ECMO evaluation.

At our institution, the patient underwent venoarterial (VA) ECMO cannulation on day of life 1, with a 12 French (Fr) venous cannula in the internal jugular vein and an 8 Fr arterial cannula in the carotid artery. Over the next 24 h, she became intermittently hypotensive, to a mean arterial pressure of 20–30 mmHg, and tachycardic, above 200 beats per minute, with decreasing ECMO flows. Despite resuscitation with blood products, she remained hemodynamically unstable with persistently low ECMO flows. Cardiac tamponade was suspected, and echocardiogram confirmed a large pericardial effusion with severely diminished biventricular systolic function (Fig. 1). With concern for possible cardiovascular perforation during ECMO cannulation, she was taken emergently for mediastinal exploration. A pericardial window was performed with drainage of 20 ml of opaque, milky fluid and immediate improvement in ECMO flows. No signs of cardiac injury, vascular perforation or hemorrhage were observed. Fluid analysis was sent (Table 1) and a right pleuro-pericardial window was created, with a 15 Fr drain placed.

Echocardiogram. (A) Apical view, pericardial effusion (white solid arrow). (B) Subcostal view, ECMO catheter tip seen entering the right atrium (white hollow arrow).
Figure 1

Echocardiogram. (A) Apical view, pericardial effusion (white solid arrow). (B) Subcostal view, ECMO catheter tip seen entering the right atrium (white hollow arrow).

Table 1

Patient’s pericardial fluid analysis.

Fluid characteristicsPatient sample
ColorWhite
Triglycerides (mg/dL)543
RBCs (%)5
Segmented neutrophils (%)37
Lymphocytes (%)1
Gram stainNo organisms
CultureNegative
CytologyNo malignant cells
Fluid characteristicsPatient sample
ColorWhite
Triglycerides (mg/dL)543
RBCs (%)5
Segmented neutrophils (%)37
Lymphocytes (%)1
Gram stainNo organisms
CultureNegative
CytologyNo malignant cells
Table 1

Patient’s pericardial fluid analysis.

Fluid characteristicsPatient sample
ColorWhite
Triglycerides (mg/dL)543
RBCs (%)5
Segmented neutrophils (%)37
Lymphocytes (%)1
Gram stainNo organisms
CultureNegative
CytologyNo malignant cells
Fluid characteristicsPatient sample
ColorWhite
Triglycerides (mg/dL)543
RBCs (%)5
Segmented neutrophils (%)37
Lymphocytes (%)1
Gram stainNo organisms
CultureNegative
CytologyNo malignant cells

The patient continued to improve postoperatively. She was decannulated on ECMO day 5, the pericardial drain was removed the next day and she was extubated on day of life 10. Repeat echocardiogram showed normal biventricular systolic function with complete resolution of pulmonary hypertension and no recurrent pericardial effusion. She transitioned from TPN to enteral feeds on day of life 12 and was discharged home without supplemental oxygen on day of life 40.

DISCUSSION

Recognizing cardiac tamponade in ECMO patients is challenging, as the characteristic signs are less specific, less pronounced or completely absent during ECMO [2]. The classically noted muffled heart sounds and diminished pulses are also seen with VA ECMO, as the heart is relatively empty with diminished pulsatility. Pulsus paradoxus is hardly seen as continuous flow from the ECMO pump obscures typical respiratory variations in systolic flow. Alternatively, suspicion for cardiac tamponade on ECMO should be raised with persistently low circuit flows, as the right atrial wall can compress against the venous cannula, obstructing venous return to the circuit. Supporting signs include a widened mediastinum on chest X-ray, loss of arterial wave form pulsatility, elevated central venous pressure and ongoing volume requirements to maintain circuit flows.

Echocardiogram, the diagnostic tool of choice, can be obtained quickly at bedside, with confirmed tamponade requiring urgent pericardial drainage. This rapidly improves cardiac filling, restoring venous return to the ECMO circuit and delivery of oxygenated blood systemically. While pericardiocentesis is effective, surgical drainage with pericardial window is warranted in suspected cardiovascular injury, with extension to sternotomy if hemopericardium or obvious injury is confirmed. Most cases of ECMO cannulation complicated by tamponade involve hemopericardium with a few serous effusions reported [2, 3]. To our knowledge, this is the first case reported of a milky pericardial effusion causing tamponade in a neonate following ECMO cannulation.

Neonatal milky pericardial effusions are rare, typically secondary to infection, chylopericardium or TPN via CVCs. Primary (idiopathic) chylopericardium is rare, with very few documented pediatric cases (Table 2). Patients are usually asymptomatic, with incidental cardiomegaly on chest X-ray, but can present with cough, fatigue or progressive dyspnea [4]. Treatment prioritizes reducing recurrence, decreasing the metabolic complications from persistent chyle leak and preventing mechanical sequelae, like tamponade or constrictive pericarditis. Stable patients are managed conservatively by pericardiocentesis, with strict TPN, octreotide and low-fat diets high in medium-chain triglycerides as useful adjuncts [5–7]. Surgical management is reserved for medically refractory cases or hemodynamic instability, most effective when pericardial window and thoracic duct ligation are performed [8].

Table 2

Cases of primary chylopericardium in the pediatric population between the years 2000 and 2022.

AuthorYearAgeSexSigns/symptomsConservative managementSurgical management
López-Castilla [5]20002 mMDyspnea, anorexiaPericardiocentesis + D
Low fat, MCT diet
TPN
None
Tan [6]20015 yMCough, dyspneaPericardiocentesis + D
Low fat, MCT diet
VATS + PW + L
Ossiani [11]20036 wkFFussiness, crying, perioral cyanosisPericardiocentesis + D
Low fat, MCT diet
Left thoracotomy + PW + L
Ossiani [11]200313 yMCoughPericardiocentesis + D
Low fat, MCT diet
Left thoracotomy + PW + L
Hattori [12]201115 yFAsymptomaticPericardiocentesis + DVATS + PW + L
Rivera-Beltrán [13]201316 yMInitially: asymptomatic  
1 year later: chest pain, dizziness
Lasix, Prednisone  
Low fat, MCT diet
Octreotide
1.P, D
2.Open abdominal PW + L
Karakurt [7]20144 yMDyspnea, tachypnea, cardiac tamponadePericardiocentesis + D
TPN
Octreotide
1.VATS + PW + D
2. L
Courtney [14]201410 yMRight upper quadrant pain, headache, dizziness
aDyspnea, fatigue, chest pain
PericardiocentesisPW + L (incomplete)
bThoracic duct embolization
Jasani [15]20182 yUDyspneaPericardiocentesis
Low fat, MCT diet
VATS + P
Jasani [15]20184 yUDyspneaPericardiocentesis
Low fat, MCT diet
1. VATS + P
2. Open abdominal PW + D + L
AuthorYearAgeSexSigns/symptomsConservative managementSurgical management
López-Castilla [5]20002 mMDyspnea, anorexiaPericardiocentesis + D
Low fat, MCT diet
TPN
None
Tan [6]20015 yMCough, dyspneaPericardiocentesis + D
Low fat, MCT diet
VATS + PW + L
Ossiani [11]20036 wkFFussiness, crying, perioral cyanosisPericardiocentesis + D
Low fat, MCT diet
Left thoracotomy + PW + L
Ossiani [11]200313 yMCoughPericardiocentesis + D
Low fat, MCT diet
Left thoracotomy + PW + L
Hattori [12]201115 yFAsymptomaticPericardiocentesis + DVATS + PW + L
Rivera-Beltrán [13]201316 yMInitially: asymptomatic  
1 year later: chest pain, dizziness
Lasix, Prednisone  
Low fat, MCT diet
Octreotide
1.P, D
2.Open abdominal PW + L
Karakurt [7]20144 yMDyspnea, tachypnea, cardiac tamponadePericardiocentesis + D
TPN
Octreotide
1.VATS + PW + D
2. L
Courtney [14]201410 yMRight upper quadrant pain, headache, dizziness
aDyspnea, fatigue, chest pain
PericardiocentesisPW + L (incomplete)
bThoracic duct embolization
Jasani [15]20182 yUDyspneaPericardiocentesis
Low fat, MCT diet
VATS + P
Jasani [15]20184 yUDyspneaPericardiocentesis
Low fat, MCT diet
1. VATS + P
2. Open abdominal PW + D + L

Abbreviations: wk, weeks old; m, months old; y, years old; M, male; F, female; U, unspecified sex; MCT, medium-chain triglycerides; VATS, video-assisted thoracoscopic surgery; P, pericardiectomy; PW, pericardial window; D, pericardial drain; L, ligation of thoracic duct. *Symptoms; **management of recurrence.

Table 2

Cases of primary chylopericardium in the pediatric population between the years 2000 and 2022.

AuthorYearAgeSexSigns/symptomsConservative managementSurgical management
López-Castilla [5]20002 mMDyspnea, anorexiaPericardiocentesis + D
Low fat, MCT diet
TPN
None
Tan [6]20015 yMCough, dyspneaPericardiocentesis + D
Low fat, MCT diet
VATS + PW + L
Ossiani [11]20036 wkFFussiness, crying, perioral cyanosisPericardiocentesis + D
Low fat, MCT diet
Left thoracotomy + PW + L
Ossiani [11]200313 yMCoughPericardiocentesis + D
Low fat, MCT diet
Left thoracotomy + PW + L
Hattori [12]201115 yFAsymptomaticPericardiocentesis + DVATS + PW + L
Rivera-Beltrán [13]201316 yMInitially: asymptomatic  
1 year later: chest pain, dizziness
Lasix, Prednisone  
Low fat, MCT diet
Octreotide
1.P, D
2.Open abdominal PW + L
Karakurt [7]20144 yMDyspnea, tachypnea, cardiac tamponadePericardiocentesis + D
TPN
Octreotide
1.VATS + PW + D
2. L
Courtney [14]201410 yMRight upper quadrant pain, headache, dizziness
aDyspnea, fatigue, chest pain
PericardiocentesisPW + L (incomplete)
bThoracic duct embolization
Jasani [15]20182 yUDyspneaPericardiocentesis
Low fat, MCT diet
VATS + P
Jasani [15]20184 yUDyspneaPericardiocentesis
Low fat, MCT diet
1. VATS + P
2. Open abdominal PW + D + L
AuthorYearAgeSexSigns/symptomsConservative managementSurgical management
López-Castilla [5]20002 mMDyspnea, anorexiaPericardiocentesis + D
Low fat, MCT diet
TPN
None
Tan [6]20015 yMCough, dyspneaPericardiocentesis + D
Low fat, MCT diet
VATS + PW + L
Ossiani [11]20036 wkFFussiness, crying, perioral cyanosisPericardiocentesis + D
Low fat, MCT diet
Left thoracotomy + PW + L
Ossiani [11]200313 yMCoughPericardiocentesis + D
Low fat, MCT diet
Left thoracotomy + PW + L
Hattori [12]201115 yFAsymptomaticPericardiocentesis + DVATS + PW + L
Rivera-Beltrán [13]201316 yMInitially: asymptomatic  
1 year later: chest pain, dizziness
Lasix, Prednisone  
Low fat, MCT diet
Octreotide
1.P, D
2.Open abdominal PW + L
Karakurt [7]20144 yMDyspnea, tachypnea, cardiac tamponadePericardiocentesis + D
TPN
Octreotide
1.VATS + PW + D
2. L
Courtney [14]201410 yMRight upper quadrant pain, headache, dizziness
aDyspnea, fatigue, chest pain
PericardiocentesisPW + L (incomplete)
bThoracic duct embolization
Jasani [15]20182 yUDyspneaPericardiocentesis
Low fat, MCT diet
VATS + P
Jasani [15]20184 yUDyspneaPericardiocentesis
Low fat, MCT diet
1. VATS + P
2. Open abdominal PW + D + L

Abbreviations: wk, weeks old; m, months old; y, years old; M, male; F, female; U, unspecified sex; MCT, medium-chain triglycerides; VATS, video-assisted thoracoscopic surgery; P, pericardiectomy; PW, pericardial window; D, pericardial drain; L, ligation of thoracic duct. *Symptoms; **management of recurrence.

Alternatively, many milky effusions initially suspicious for chylopericardium were found to be CVC-infused TPN in the pericardial space [9]. CVC-related pericardial effusion with tamponade occurs in 1–3% of neonates, with a 30–50% mortality [1]. Originally thought to be secondary to right atrial perforation by a deep CVC, persistent events despite appropriate catheter position leave the true underlying mechanism unknown. Nevertheless, early diagnosis is critical, requiring prompt pericardial drainage, TPN discontinuation and CVC removal [1, 10].

The etiology of our patient’s milky pericardial effusion remains a mystery. Table 3 compares our fluid sample to other characteristically milky pericardial effusions. Negative cultures with no organisms on gram stain rule out infection. Despite high triglycerides, the lack of lymphocyte predominance makes chylopericardium less likely. Although a TPN-associated infusion is possible, lack of recurrence, despite continuing TPN with the same CVC, seems unlikely. Though she responded well to primary surgical drainage without recurrence, this case highlights the importance of a comprehensive differential, as second steps, further diagnostics and adjunctive treatments vary significantly.

Table 3

Comparison of milky pericardial fluid characteristics by etiology [4, 9].

Fluid characteristicsPatient sampleInfectionChylopericardiumTPN-associated effusion
Gross appearanceWhiteWhite/yellow (Turbid)White/milkyWhite/milky
TriglyceridesHighLowHighHigh
Segmented neutrophilsModHighLowLow
LymphocytesLowLowHighLow
Gram stainNo organismsPositiveNegativeNegative
CultureNegativePositiveNegativeNegative
Fluid characteristicsPatient sampleInfectionChylopericardiumTPN-associated effusion
Gross appearanceWhiteWhite/yellow (Turbid)White/milkyWhite/milky
TriglyceridesHighLowHighHigh
Segmented neutrophilsModHighLowLow
LymphocytesLowLowHighLow
Gram stainNo organismsPositiveNegativeNegative
CultureNegativePositiveNegativeNegative
Table 3

Comparison of milky pericardial fluid characteristics by etiology [4, 9].

Fluid characteristicsPatient sampleInfectionChylopericardiumTPN-associated effusion
Gross appearanceWhiteWhite/yellow (Turbid)White/milkyWhite/milky
TriglyceridesHighLowHighHigh
Segmented neutrophilsModHighLowLow
LymphocytesLowLowHighLow
Gram stainNo organismsPositiveNegativeNegative
CultureNegativePositiveNegativeNegative
Fluid characteristicsPatient sampleInfectionChylopericardiumTPN-associated effusion
Gross appearanceWhiteWhite/yellow (Turbid)White/milkyWhite/milky
TriglyceridesHighLowHighHigh
Segmented neutrophilsModHighLowLow
LymphocytesLowLowHighLow
Gram stainNo organismsPositiveNegativeNegative
CultureNegativePositiveNegativeNegative

Cardiac tamponade can be life-threatening and is challenging to diagnose in patients on ECMO. A high index of suspicion, familiarity with ECMO physiology and prompt echocardiography prevents diagnostic delays, decreasing morbidity and mortality for neonates. Comprehensive workup for milky pericardial effusions can guide further steps in management, reducing immediate and potential long-term complications.

CONFLICT OF INTEREST STATEMENT

None declared.

FUNDING

None.

DATA AVAILABILITY

The data supporting the conclusions of this article are included in the article.

References

1.

Warren
 
M
,
Thompson
 
KS
,
Popek
 
EJ
,
Vogel
 
H
,
Hicks
 
J
.
Pericardial effusion and cardiac tamponade in neonates: sudden unexpected death associated with Total parenteral nutrition via central venous catheterization
.
Ann Clin Lab Sci
 
2013
;
43
:
163
71
.

2.

Morcos
 
M
,
Vincent
 
L
,
Harari
 
R
,
Badulak
 
J
,
Chen
 
M
.
Cardiac tamponade in venoarterial extracorporeal membrane oxygenation
.
Echocardiography
 
2021
;
38
:
1465
70
.

3.

Kurian
 
MS
,
Reynolds
 
ER
,
Humes
 
RA
,
Klein
 
MD
.
Cardiac tamponade caused by serous pericardial effusion in patients on extracorporeal membrane oxygenation
.
J Pediatr Surg
 
1999
;
34
:
1311
4
.

4.

Dib
 
C
,
Tajik
 
AJ
,
Park
 
S
,
Kheir
 
MEL
,
Khandieria
 
B
,
Mookadam
 
F
.
Chylopericardium in adults: a literature review over the past decade (1996-2006)
.
J Thorac Cardiovasc Surg
 
2008
;
136
:
650
6
.

5.

López-Castilla
 
JD
,
Soult
 
JA
,
Falcón
 
JM
,
Muñoz
 
M
,
Santos
 
J
,
Gavilan
 
JL
, et al.   
Primary idiopathic chylopericardium in a 2 month old successfully treated without surgery
.
J Pediatr Surg
 
2000
;
35
:
646
8
.

6.

Tan
 
JX
,
Fu
 
Y
,
Chen
 
J
.
Primary idiopathic chylopericardium: a case report
.
Cardiol Young
 
2013
;
23
:
773
5
.

7.

Karakurt
 
C
,
Çelik
 
SF
,
Çelik
 
RM
,
Elkiran
 
Ö
,
Ulutaş
 
H
,
Kuzucu
 
A
.
Primary idiopathic chylopericardium presenting with cardiac tamponade
.
Herz
 
2014
;
39
:
644
6
.

8.

Han
 
Z
,
Li
 
S
,
Jing
 
H
,
Liu
 
H
.
Primary idiopathic chylopericardium: a retrospective case series
.
BMC Surg
 
2015
;
15
:
61
.

9.

Zasada
 
IA
,
Banner
 
J
,
Bugge
 
A
.
‘Nutrition or no nutrition?’: chylothorax or leakage of total parenteral nutrition?
 
Forensic Sci Med Pathol
 
2019
;
15
:
470
3
.

10.

Campbell
 
CR
,
Benson Ham
 
P
,
Pipkin
 
W
,
Hatley
 
R
,
Christian Walters
 
K
.
Total parenteral nutrition lipid emulsion pleural and pericardial effusions may present similar chylothorax with milky white chest tube output after tracheoesophageal fistula repair
.
Am Surg
 
2018
;
84
:
E357
9
.

11.

Ossiani
 
MH
,
Mccauley
 
RGK
,
Patel
 
HT
,
Ossiani
 
MH
,
Mccauley
 
ARGK
,
Patel
 
HT
.
Primary idiopathic chylopericardium case report
.
Pediatr Radiol
 
2003
;
33
:
357
9
.

12.

Hattori
 
H
,
Dakeshita
 
E
,
Nakazato
 
J
,
Takahashi
 
T
,
Wake
 
M
,
Hirata
 
K
, et al.   
Primary chylopericardium treated by surgery: report of two cases
.
J Cardiol Cases
 
2011
;
3
:
e106
10
.

13.

Rivera-Beltrán
 
S
,
Ortíz
 
VN
,
Díaz
 
R
,
Hernández
 
JA
.
Transabdominal ligation of the thoracic duct with pericardial-peritoneal shunting in a case of primary idiopathic chylous pericardial effusion
.
J Pediatr Surg
 
2013
;
48
:
1434
7
.

14.

Courtney
 
M
,
Ayyagari
 
RR
.
Idiopathic chylopericardium treated by percutaneous thoracic duct embolization after failed surgical thoracic duct ligation
.
Pediatr Radiol
 
2015
;
45
:
927
30
.

15.

Jasani
 
M
,
Shah
 
A
,
Shah
 
A
.
Pediatric Chylopericardium: treatment conundrum
.
J Indian Assoc Pediatr Surg
 
2018
;
23
:
51
2
.

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.